scope:

Abstract

Clinical and Laboratory Standards Institute document M24S-Performance Standards for Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes includes the minimal inhibitory concentrations and QC ranges developed following the standards described in CLSI document M24.¹ The data in the tables are valid only when the methodology in CLSI document M24¹ is followed.

Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes. 2nd edition. CLSI supplement M24S (ISBN 978-1-68440-168-0 [Print]; ISBN 978-1-68440-169-7 [Electronic]). Clinical and Laboratory Standards Institute, USA, 2023.

Copyright ©2023 Clinical and Laboratory Standards Institute. Except as stated below, any reproduction of content from a CLSI copyrighted standard, guideline, derivative product, or other material requires express written consent from CLSI. All rights reserved. Interested parties may send permission requests to permissions@clsi.org.

CLSI hereby grants permission to each individual member or purchaser to make a single reproduction of this publication for use in its laboratory procedures manual at a single site. To request permission to use this publication in any other manner, e-mail permissions@clsi.org.